Brian Hess

Brian founded RevBio in 2014 with the goal of commercializing TETRANITE®, a regenerative bone adhesive with 8+ patents. The game changing biomaterial platform promises to transform bone repair across a body of human and animal indications. Brian co-invented this technology while at Stryker Corporation where he received the 2010 Innovator of the Year Award for this novel invention. During his tenure at Stryker, Brian also developed and launched HydroSet™, a commercially successful synthetic bone substitute, which is a key predicate to RevBio’s TETRANITE technology. Prior to founding RevBio, Brian was the Chief Technology Officer at InVivo Therapeutics where he led the R&D organization which developed a Class III biomaterial that gained FDA approval (to evaluate its use in clinical trials for treating patients with traumatic spinal cord injury). Brian is co-inventor and holder of over 15 patents. He received his BS in Mechanical Engineering from the UW-Madison and his MBA from the MIT Sloan School of Management.